Ascendis Pharma A (ASND) Return on Capital Employed [ROCE] (2015 - 2026)
Ascendis Pharma A (ASND) reported Return on Capital Employed [ROCE] of 15.79% for the quarter ended Jun 30, 2026, up 254.02 percentage points from -238.22% a year earlier and up 16.86 percentage points from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Ascendis Pharma A posted Return on Capital Employed [ROCE] of -12.52%, up 27.31 percentage points from the prior year.
- Return on Capital Employed [ROCE] has a five-year change of +15.23 percentage points (years ended Dec 2020 to Dec 2025).
- By year, Return on Capital Employed [ROCE] came in at -39.83% in the year ended Dec 31, 2024 (+180.06 pp), -219.89% in the year ended Dec 31, 2023 (-149.91 pp), -69.98% in the year ended Dec 31, 2022 (-42.43 pp) and -27.55% in the year ended Dec 31, 2021 (+0.20 pp).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Return on Capital Employed [ROCE] in data going back to the quarter ended Mar 31, 2015.
- Year over year, Return on Capital Employed [ROCE] gained in five of the last seven quarters, with an average year-over-year change of +541.18 percentage points.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was the quarter ended Mar 31, 2025 (a gain of 3222.88 percentage points); the low point was the quarter ended Mar 31, 2024 (a drop of 3180.50 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -1.07% (quarter ended Mar 31, 2026), -77.11% (quarter ended Dec 31, 2025) and -113.70% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Ascendis Pharma A | 14.09 Bn | 10.33 Bn | 362.22 Mn | 15.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.79% |
| Mar 31, 2026 | -1.07% |
| Dec 31, 2025 | -77.11% |
| Sep 30, 2025 | -113.70% |
| Jun 30, 2025 | -238.22% |
| Mar 31, 2025 | -27.46% |
| Dec 31, 2024 | -33.35% |
| Sep 30, 2024 | -388.80% |
| Mar 31, 2024 | -3,250.34% |
| Dec 31, 2023 | -388.46% |
| Sep 30, 2023 | -87.29% |
| Jun 30, 2023 | -79.67% |
| Mar 31, 2023 | -69.84% |
| Dec 31, 2022 | -166.64% |
| Sep 30, 2022 | -47.24% |
| Jun 30, 2022 | -39.63% |
| Mar 31, 2022 | -29.22% |
| Dec 31, 2021 | -32.97% |
| Sep 30, 2021 | -47.89% |
| Jun 30, 2021 | -49.30% |
API Access
Ascendis Pharma A Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();